Back to Journals » Infection and Drug Resistance » Volume 11

Original Research

Defining the potency of amikacin against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii derived from Chinese hospitals using CLSI and inhalation-based breakpoints

       
Total article views   HTML views PDF downloads Totals
18,614 Dovepress* 14,014+ 1,424 15,438
PubMed Central* 4,600 374 4,974
Totals 18,614 1,798 20,412
*Since 25 May 2018
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar